Additionally, APOC1 depletion has been demonstrated to promote ferroptosis in HCC, which enhances immune activation, reverses M2 differentiation of TAMs, and improves the efficacy of anti-PD1 immunotherapy in HCC[37]. The gene discussed is APOC1; the disease is hepatocellular carcinoma.